tiprankstipranks
Trending News
More News >
Clemondo Group AB (SE:CLEM)
:CLEM
Advertisement

Clemondo Group AB (CLEM) AI Stock Analysis

Compare
0 Followers

Top Page

SE:CLEM

Clemondo Group AB

(Frankfurt:CLEM)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
Clemondo Group AB's stock score reflects a balanced view of its financial performance, technical indicators, and valuation. The company exhibits stable but pressured financials, with technicals showing positive momentum. However, the absence of earnings call and corporate event data limits further insights.

Clemondo Group AB (CLEM) vs. iShares MSCI Sweden ETF (EWD)

Clemondo Group AB Business Overview & Revenue Model

Company DescriptionClemondo Group AB (publ) develops, manufactures, and sells a range of cleaning products in Sweden. It provides cleaning solutions for vehicle; cutting fluids and lubricants, aerosols, food, and cleaning and disinfection industries; and sanitary facilities, public areas, laundry and detergent, floor cleaning, windows and mirrors, surface disinfection, and kitchen. The company also offers soap and hygiene products, such as soap, hand and skin cream, hand disinfection, and hair and body wash products, as well as other equipment. It sells its products under its Lahega, Liv, and Strovels brands, as well as through private labels. The company was formerly known as NC Lahega AB (publ) and changed its name to Clemondo Group AB (publ) in May 2017. Clemondo Group AB (publ) was founded in 1952 and is headquartered in Helsingborg, Sweden.
How the Company Makes MoneyClemondo Group AB makes money primarily through the sale of its chemical products to various industries. The company's revenue streams include direct sales to businesses within the automotive, industrial, and hygiene sectors, where its products are used for maintenance and cleaning purposes. Clemondo also benefits from partnerships with distributors and retailers to expand its market reach. Additionally, the company focuses on providing eco-friendly solutions, which can attract customers looking for sustainable and compliant products, contributing to its earnings.

Clemondo Group AB Financial Statement Overview

Summary
Clemondo Group AB faces challenges with declining revenues and profitability pressures. The balance sheet reflects improved debt management but raises concerns over leverage. Cash flow is stable yet strained, posing risks to future investments.
Income Statement
65
Positive
Clemondo Group AB has experienced fluctuations in its revenue over recent years, with a notable decline in total revenue from 2020 to 2024. The gross profit margin remains relatively stable, indicating efficient cost management. However, the net profit margin has decreased significantly, highlighting challenges in profitability. Despite a decent EBIT margin, the company faces pressure on net income and EBITDA margins, suggesting increasing operational costs or other financial strains.
Balance Sheet
60
Neutral
The company's debt-to-equity ratio has improved over time, reflecting positive efforts in managing debt levels. The return on equity (ROE) has seen a downward trend, indicating challenges in generating profits from shareholders' equity. The equity ratio suggests a stable financial foundation, but the overall leverage remains a concern, which could impact financial stability amid fluctuating revenues.
Cash Flow
68
Positive
Free cash flow has shown variability, with a recent decline in growth, indicating potential challenges in sustaining cash generation. The operating cash flow to net income ratio is healthy, suggesting strong cash conversion efficiency. However, the free cash flow to net income ratio indicates some pressure on maintaining liquidity. Overall, the cash flow position is stable but shows signs of strain that could impact future investments and operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue276.12M262.06M278.90M299.20M301.53M359.13M
Gross Profit104.25M97.56M100.62M99.49M122.90M149.89M
EBITDA25.97M24.61M30.48M23.63M38.90M68.24M
Net Income7.35M6.17M9.96M3.76M17.02M38.08M
Balance Sheet
Total Assets217.14M181.34M187.78M212.34M217.63M228.15M
Cash, Cash Equivalents and Short-Term Investments0.000.001.13M-42.55M1.09M0.00
Total Debt53.93M22.46M29.67M53.03M65.13M88.25M
Total Liabilities100.75M68.12M76.40M110.92M124.64M152.18M
Stockholders Equity116.39M113.23M111.39M101.43M92.99M75.97M
Cash Flow
Free Cash Flow6.01M5.78M26.91M8.61M27.13M64.22M
Operating Cash Flow12.18M9.82M27.20M9.10M28.23M68.62M
Investing Cash Flow-6.16M-4.05M-286.00K-31.00K-1.10M-4.25M
Financing Cash Flow-6.01M-6.90M-25.79M-10.16M-26.04M-64.37M

Clemondo Group AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price9.95
Price Trends
50DMA
9.87
Negative
100DMA
10.01
Negative
200DMA
8.91
Positive
Market Momentum
MACD
-0.23
Positive
RSI
39.45
Neutral
STOCH
45.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CLEM, the sentiment is Negative. The current price of 9.95 is above the 20-day moving average (MA) of 9.46, above the 50-day MA of 9.87, and above the 200-day MA of 8.91, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 39.45 is Neutral, neither overbought nor oversold. The STOCH value of 45.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CLEM.

Clemondo Group AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
€127.39M17.346.34%5.89%10.59%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:CLEM
Clemondo Group AB
9.20
1.68
22.36%
DE:8Y1
Axolot Solutions Holding AB
0.03
<0.01
50.00%
DE:PXO
Poolia AB Class B
0.54
-0.04
-6.90%
DE:9T2
Nordic LEVEL Group AB Class B
0.04
-0.02
-33.33%
DE:CRB
CirChem AB
0.16
-0.06
-27.27%
DE:651
LifeClean International AB
0.01
-0.22
-95.65%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 08, 2025